The almost unique arrangement by which our department and institute render ophthalmological services exclusively to a large population offers an excellent opportunity for long-term studies. Taking advantage of this we analysed the follow-up records over an 11-year period of all patients treated for AACG who had been followed up for at least one year after the attack, and we attempted to analyse the influence of factors prior to surgery on the late outcome of AACG.
how long after beginning treatment the attack was terminated; (5) final outcome one year or later after the attack, namely, 'cured' with no additional medical treatment; 'not cured' needing continuous medical therapy, and/or having glaucomatous damage, and/or needing further glaucoma surgery.
All data were fed into the computer and the relationship between the various parameters analysed. Statistical significance was tested by the x2 method.
In this study we examined the final outcome of each case and related it to three preoperative data, namely, delay in presentation, height of the IOP during the attack, and the time needed to terminate the attack by conventional medical therapy.
Results
Delay in presentation. For 94 patients who were followed up for at least one year information was available on the time elapsing between the onset of symptoms and start of treatment. Table 1 The importance of the delay in presentation as seen in Table 1 indicates that patients arriving, diagnosed, and treated within 24 hours less often have a late increase in IOP than those who present later. The fact that the height of the IOP during the acute attack has no effect on the final outcome has been reported previously4 and was confirmed in this study.
Our results also indicate the importance of the duration of the attack, as expressed both by the delay in presentation and by the time elapsing between initiation of treatment and until the termination of the attack. The longer the time between presentation and termination of the attack, the higher is the risk for a future elevation of the IOP. Analysis of the data showed that most of the cases with delayed presentation were also relieved of their attack after a longer period of time. We therefore assume that the time factor plays an important role in the formation of peripheral anterior synechiae, iris atrophy with pigment deposits in the angle, etc, factors which later interfere with the normal angle filtration.
The effect of delay in presentation was previously investigated by Hillman,6 who did not find it to be related to the final IOP. Our study re-examined the effects of delay in presentation and the time needed to terminate the attack, and we found that this duration of the AACG attack certainly has a detrimental effect on the long term outcome of the affected eye.
Playfair and Watson4 reported that all the changes in their patients occurred within four months after the attack. Though we examined our results at least one year later, in retrospect we can state that a careful follow-up of 6-12 months is probably sufficient in those 70-75% of cases which will be troublefree and may be discharged from follow-up, as they can be considered cured. 
